Instructing durable humoral immunity for COVID-19 and other vaccinable diseases

D Bhattacharya - Immunity, 2022 - cell.com
Immunity, 2022cell.com
Many aspects of SARS-CoV-2 have fully conformed with the principles established by
decades of viral immunology research, ultimately leading to the crowning achievement of
highly effective COVID-19 vaccines. Nonetheless, the pandemic has also exposed areas
where our fundamental knowledge is thinner. Some key unknowns are the duration of
humoral immunity post-primary infection or vaccination and how long booster shots confer
protection. As a corollary, if protection does not last as long as desired, what are some ways …
Summary
Many aspects of SARS-CoV-2 have fully conformed with the principles established by decades of viral immunology research, ultimately leading to the crowning achievement of highly effective COVID-19 vaccines. Nonetheless, the pandemic has also exposed areas where our fundamental knowledge is thinner. Some key unknowns are the duration of humoral immunity post-primary infection or vaccination and how long booster shots confer protection. As a corollary, if protection does not last as long as desired, what are some ways it can be improved? Here, I discuss lessons from other infections and vaccines that point to several key features that influence durable antibody production and the perseverance of immunity. These include (1) the specific innate sensors that are initially triggered, (2) the kinetics of antigen delivery and persistence, (3) the starting B cell receptor (BCR) avidity and antigen valency, and (4) the memory B cell subsets that are recalled by boosters. I further highlight the fundamental B cell-intrinsic and B cell-extrinsic pathways that, if understood better, would provide a rational framework for vaccines to reliably provide durable immunity.
cell.com